Patent News for Friday 14th February 2025

1. New ANDA Cases - Winter 2024 | Robins Kaplan LLP - JDSupra

This chart summarizes the case name, presiding judge, drug, and patents-at-issue in all federal district court cases that are filed pursuant to ...

2. European Commission withdraws key technology regulations - ICLG.com

Specifically, the affected proposals include a framework for standard essential patents (SEPs), the AI Liability Directive and enhanced privacy ...

3. 'New GMO' Deregulation: Europe's Small-Scale Farmers and Breeders Warn of Corporate ...

... patents, identification and detection methods, price of seeds, seed diversity, coexistence, negative socioeconomic impacts and risk of further ...

4. BioVaxys Announces Application for Management Cease Trade Order - FirstWord Pharma

... patents. Dale Matheson Carr-Hilton LaBonte LLP ("DMCL"), the Company's auditor, has advised the Company that it may be unable to complete its ...

5. Office of controller general of patents only its admin fin division shifting to Delhi Goyal

New Delhi, Feb 13 (PTI) Commerce and Industry Minister Piyush Goyal on Thursday said only the office of the Controller General of Patents, ...

6. Wind power patents: Siemens Gamesa | TotalEnergies | Vestas - Windpower Monthly

The following patents were processed in the period 7-13 February: North America. GE Vernova-owned LM Wind Power submitted a patent application for ...

7. From Fujifilm to Nikon: Are These 8 Lens Patents Worth Your Time? - The Phoblographer

Innovations must not stop in photography. It now appears that four camera and lens manufacturers have filed for new lens patents, each of which ...

8. European Commission Withdraws SEP Regulation - Lexology

Among 35 initiatives the European Commission plans to withdraw is the proposed regulation on Standard Essential Patents (SEPs). Other notable…

9. Mallinckrodt Fails To Halt Airgas' Generic Nitric Oxide Drug - Law360 Healthcare Authority

... didn't show enough evidence that Airgas infringed its patents or that it would suffer irreparable harm.

10. On our radar… Nokia defeats Amazon in patent scuffle, Tencent's video feud, Gucci's ...

Patents · On our radar… Nokia defeats Amazon in patent scuffle, Tencent's video feud, Gucci's clampdown on counterfeits. Andrei Antipov ...

11. Brown Rudnick Names Erick Robinson and Jayne Piana as Co-Chairs of PTAB Practice

... patents being asserted against Meta Platforms and claims of three patents being asserted against Sony Interactive Entertainment. The team also ...

12. 10 Amazing Patent Protected Game Mechanics - DualShockers

Patents for video game mechanics are rare, thankfully. While the frustration of having a good idea copied is understandable, patents can severely ...

13. Envoy Medical Secures Additional Patent Protection for Its Growing Patent Portfolio

Envoy Medical strengthens intellectual property with 6 new patents spanning US, Japan, and Hong Kong, covering advanced cochlear implant ...

14. Envoy Medical secures new patents for cochlear implants - Investing.com

The Japanese Patent Office awarded Envoy Medical three patents on December 2 and 3, 2024, related to cochlear implant systems with a common power ...

15. Meta hopes to woo Commission while Parliament still in love with American tech - Euractiv

Plus, Parliament and Council were blindsided by the Commission's withdrawal on Standard Essential Patents, but the EU's Patents Office was not.

16. Schneider patents the use of AI to reduce industrial hazards - Drives & Controls

Schneider patents the use of AI to reduce industrial hazards. 14 February 2025. Schneider's patent covers the use of AI to enhance risk assessments ...

17. US rejects most of Nintendo's anti-Palworld patent claims - Thred Website

However, as patents are region-specific, they can only be applied in Japan. The lawsuit does not affect the game anywhere ...

18. Bio-Path Holdings Expands Global Patent Portfolio - CBS47 and KSEE24

... patents in the United States and New Zealand, and updated investors on ... 741793 titled, “P-ethoxy nucleic acids for liposomal formulation.” These new ...

19. Propanc Biopharma, Inc. SEC 10-Q Report - TradingView

These patents relate to the use of proenzymes against solid tumors, covering the lead product candidate PRP. Reverse Stock Split: The company has ...

20. Roche patents new SIK inhibitors - BioWorld

Roche patents new SIK inhibitors ... An exemplified compound (Ex 9 pg 48, claim 14) inhibited SIK1, SIK2 and SIK3 activity (IC50=0.067, 0.0007 and ...

21. USP1 inhibitors detailed in Laekna Therapeutics patents - BioWorld

Laekna Therapeutics Shanghai Co. Ltd. patents describe new ubiquitin carboxyl-terminal hydrolase 1 (USP1) inhibitors potentially useful for the ...

22. Case Study: Automotive Manufacturing Expert Needed For Patent Dispute - Mondaq

... major vehicle manufacturer, alleging that the manufacturer's automated assembly systems used in automotive manufacturing infringed two patents...

23. ITC Enforces Import Ban on Power Modules Following Vicor Patent Victory | VICR Stock News

ITC issues exclusion order protecting Vicor patents, banning unlicensed power module imports. Some companies already securing licenses as legal ...

24. ITC bars importation of power modules and unlicensed computing systems that infringe Vicor patents

ITC bars importation of power modules and unlicensed computing systems that infringe Vicor patents. Vicor Corporation - (GLOBE NEWSWIRE); Feb 14 ...

25. ITC bars importation of power modules and unlicensed computing systems that infringe Vicor patents

The Final Determination reversed a prior finding that Foxconn Respondents did not have a license to Vicor patents and instead found that two ...

26. ITC bars importation of power modules and unlicensed computing systems that infringe Vicor patents

The Final Determination reversed a prior finding that Foxconn Respondents did not have a license to Vicor patents and instead found that two Foxconn ...

27. Resolving Claim Ambiguity via Reissue | Sterne, Kessler, Goldstein & Fox P.L.L.C.

Later, TVnGO sought reissue of the '969 and the '220 patents, respectively. In the '969 patent's reissue, (application No. 17/867,612) TVnGO ...

28. Cavitation Technologies, Inc. SEC 10-Q Report - TradingView

... patents. Gross Profit: $63,000, reflecting a decrease of 60.1% from the prior year, primarily due to lower revenue. Loss from operations ...

29. Women in IP: Protecting LinkedIn's "billion-dollar brand" - IAM Media

Head of IP Renee Brown discusses her role safeguarding the Microsoft-owned social media company's patents, copyrights, trademarks and brand - and ...

30. Madras High Court Upholds Rejection Of AI-Human Integration Patent Claim - LiveLaw

... Patents. Upon review, the court found no sufficient grounds to interfere with the Controller's decision and accordingly rejected the appeal. Facts ...

31. ASUSTeK Hit with $10.5M Verdict in High-Stakes Patent Showdown - USA Herald

The patents in question—U.S. Patent Nos. 7,629,634 and 7,812,409—cover a specialized transistor technology used in integrated circuits. Force Mos, ...

32. Envoy Medical Secures Additional Patent Protection for Its Growing Patent Portfolio - Yahoo Finance

These three Japanese patents share a common title: Implantable Cochlear System with Integrated Components and Lead Characterization. STORY_CONTINUES.

33. Patent Trial and Appeals Board (PTAB) - Brown Rudnick

Quantum Imaging in successful defense of three patents against inter partes review petitions filed by Sony Interactive Entertainment. Thaddeus Gabara ...

34. FMC downgraded to Neutral from Buy at Redburn Atlantic | Markets Insider

... patents, think they are not as “ironclad as active ingredient patents.” It believes heightened generic competition could lead to further ...

35. Envoy Medical Secures Additional Patent Protection for Its Growing Patent Portfolio

These three Japanese patents share a common title: Implantable Cochlear System with Integrated Components and Lead Characterization. The Hong Kong ...

36. Federal Circuit: Written Description and Enablement Depend on What a Patent 'Claims,' Not ...

In response, Novartis brought suit in the District of Delaware alleging infringement of one of its patents directed to pharmaceutical compositions of ...